Jennifer Le Guévelou, Editorial Board Member at Cancer Radiotherapie, shared on LinkedIn:
“I am truly grateful to have had the opportunity to attend the APEX congress and to present data on cardio-oncology, in patients with prostate cancer.
It was an outstanding experience, bringing together experts from every continent and fostering high-level scientific exchange. The quality of the presentations was exceptional, reflecting the latest advances in oncology and offering valuable insights into the care of patients with prostate cancer.
These discussions open the door for future collaborations, and I look forward to continuing to work with this amazing international community.”
APEX Cancer Care operates as the specialized oncology division of Urology Austin. Rather than treating prostate cancer in a general setting, APEX is structured as a dedicated ‘center of excellence’ specifically for men dealing with high-risk, recurrent, or metastatic disease.
- Team-Based Care. Instead of sending patients to separate clinics for different treatments, APEX brings urologists, medical oncologists, and radiation oncologists together under one coordinated care plan.
- Focus on Advanced Disease. While early-stage prostate cancer is often managed with surgery or standard radiation, APEX focuses heavily on complex cases – such as cancer that has returned after initial treatment (biochemical recurrence) or spread beyond the prostate.
- Access to Newer Therapies. Because it is a specialized oncology network, patients have direct access to newer treatments that require specialized handling, including targeted radiopharmaceuticals, advanced hormone therapies, immunotherapies, and ongoing clinical trials.
- Precision Testing. Their protocols emphasize genetic and molecular profiling of the tumor to see if a patient qualifies for targeted medications rather than relying solely on standard chemotherapy.

Other articles from APEX 2026 on OncoDaily.